Research & Development

Breaking Away From Tradition

Breaking away from tradition is the aim of the game for Curemark, with the company’s novel therapies intended to make…

The Role Of Data In Drug Discovery

We spoke to IDBS Biologics Development Solution Owner, Unjulie Bhanot to discuss the pivotal role of data in drug discovery,…

Swiss Medical Device Company Seeks Research Partners,…

Ava AG, the Swiss medical device company, is calling for research collaboration or funding to study the potential utility of…

Investment from IW Capital to drive rapid…

Flarin is a unique and patent protected lipid formulated ibuprofen which at a dose of 1200 mg/day has shown to…

Medicinal cannabis – pharma’s budding opportunity?

As a sector, the global cannabis extract market is expected to be worth USD 23.7 billion by 2025. So, what…

The challenges of developing ethical pet food

Natural pet food company Scrumbles discuss the ethical problems behind the pet food industry and how they overcame them.

Patient-centricity: the ultimate promise of blockchain for…

Thanks to innovations in enterprise blockchain technology, a technological shift in the healthcare industry is fast becoming a reality, disrupting…

Are you IP-ready for an IPO?

A recent upturn in European biopharma IPO activity could be a sign of growing investor confidence and other innovative businesses…

Helping surgeons work without fear of infection…

New research shows that in fact an overwhelming majority of surgeons have had a close encounter with a serious risk…